Growth Metrics

PROCEPT BioRobotics (PRCT) Equity Ratio (2020 - 2026)

PROCEPT BioRobotics has reported Equity Ratio over the past 7 years, most recently at 0.71 for Q1 2026.

  • Quarterly Equity Ratio fell 4.73% to 0.71 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.71 through Mar 2026, down 4.73% year-over-year, with the annual reading at 0.72 for FY2025, 4.39% down from the prior year.
  • Equity Ratio was 0.71 for Q1 2026 at PROCEPT BioRobotics, down from 0.72 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.79 in Q1 2022 and troughed at 0.57 in Q2 2023.
  • The 5-year median for Equity Ratio is 0.71 (2023), against an average of 0.7.
  • Year-over-year, Equity Ratio decreased 25.61% in 2023 and then grew 17.54% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.64 in 2022, then grew by 8.88% to 0.69 in 2023, then increased by 8.58% to 0.75 in 2024, then fell by 4.39% to 0.72 in 2025, then decreased by 0.87% to 0.71 in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Equity Ratio are 0.71 (Q1 2026), 0.72 (Q4 2025), and 0.74 (Q3 2025).